J&J hip patient feared surgery would kill him; Boston Scientific faces German patent suit;

 @FierceMedDev: Dune gains CE mark for next gen-breast cancer Dx tool. News | Follow @FierceMedDev

 @MarkHFierce: Hmm, the second med device venture funding in two days. This time, a focus on uterine fibroid ablation. Release | Follow @MarkHFierce

 @DamianFierce: Thanks to investor excitement, Life Technologies might now be too pricey for a sale. More | Follow @DamianFierce

> A plaintiff in one of Johnson & Johnson's ($JNJ) more than 10,000 all-metal hip lawsuits testified that he feared he would die if he got revision surgery after his ASR implant failed. Article

> Germany's OrbusNeich Medical is suing Boston Scientific ($BSX) for patent infringement, claiming stents including Promus and Omega violate its European patents. News

> Covidien ($COV) has wrapped up enrollment in two multinational studies designed to test whether its stents are safe and effective in treating iliac artery disease. More

> Life Technologies ($LIFE) is rolling out 12 new technologies that support its Ion Torrent gene sequencing platform. Release

> Tennessee diagnostics outfit Diagnovus has launched the first commercial gene expression assay for patients with diffuse large B-cell lymphoma. Item

> In Dubai, industry magnates are predicting big growth for the Arab medical device market, currently valued at $1 billion per year. Story

Biotech News

 @FierceBiotech: If you missed it yesterday, check out @RyanMFierce's feature on FierceBiotechIT.com : Top 10 Biotech Techies, 2013. Special Report | Follow @FierceBiotech

 @JohnCFierce: Interesting biotech model: NC development team nabs $5M angel tranche for their latest biotech play. Story | Follow @JohnCFierce

> Chelsea rebounds after FDA agrees to take a look at new Northera data. News

> Star-crossed Merck reorganizes troubled biosimilars effort around Samsung pact. Report

> MDxHealth hits testing milestone with prostate cancer epigenetic Dx. Item

Pharma News

 @FiercePharma: Chinese government plans to cut the number of drug wholesalers to 3K from 13K. Pharma stocks there rose on the news. More | Follow @FiercePharma

 @EricPFierce: Gilead, Teva now making nice over Viread patent, ending years of litigation. News | Follow @EricPFierce

 @AlisonBFierce: HealthMap has expanded its reach, allowing people to search for any of 11 vaccines available near their home. Story | Follow @AlisonBFierce

> Gilead, Teva wrap up Viread patent fight. News

> Italian antitrust agency probes alleged Roche-Novartis cartel. Report

> Study: ED drugmakers aren't properly policing their TV ads. Story

Drug Delivery News

> Lentigen's stem cell delivery for brain tumors nets FDA orphan status. News

> PolyActiva seeks drug partner for new intraocular delivery implant. Report

> Oramed presses forward into PhII with oral insulin pill. Story

> EpiVax, Novozymes fuse drug, delivery protein with $3B market at hand. Item

Biomarkers News

> NIH pours $900K into Parkinson's biomarker research. News

> Alzheimer's biomarkers indicate dementia advancement. More

> Mayo study spotlights new biomarkers for quick kidney injury alert. Report

> NYU investigative team on the trail of PTSD biomarkers. Article

> Nanomix plans test of triple biomarker heart attack Dx. Story